Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Journal of Genetics and Genomics = Yi Chuan Xue Bao|July 4, 2012
Automated behavioral phenotyping reveals presymptomatic alterations in a SCA3 genetrap mouse modelJeannette Hübener, Nicolas Casadei, Peter Teismann, et al.
Neuroscience Letters|October 11, 2003
TorsinA protects against oxidative stress in COS-1 and PC12 cellsRohini Kuner, Peter Teismann, Annette Trutzel, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2003
Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegenerationPeter Teismann, Kim Tieu, Dong-Kug Choi, et al.
Neurobiology of Aging|January 10, 2012
Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicityPeter Teismann, Kinnari Sathe, Angelika Bierhaus, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 23, 2003
Pathogenic role of glial cells in Parkinson's diseasePeter Teismann, Kim Tieu, Oren Cohen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 7, 2002
Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson diseaseD C Wu, Vernice Jackson-Lewis, Miquel Vila, et al.
Annals of Neurology|July 6, 2004
L-3-hydroxyacyl-CoA dehydrogenase II protects in a model of Parkinson's diseaseKim Tieu, Celine Perier, Miquel Vila, et al.
The Journal of Clinical Investigation|September 17, 2003
D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson diseaseKim Tieu, Celine Perier, Casper Caspersen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 15, 2005
Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in miceDong-Kug Choi, Subramaniam Pennathur, Celine Perier, et al.
Neurobiology of Disease|February 28, 2016
In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizinMatteo Santoro, Walter Maetzler, Petros Stathakos, et al.
Pageof 4